Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The kinetoplastid proteasome is a large, multisubunit enzyme complex found in kinetoplastid parasites, such as *Trypanosoma cruzi*, *Leishmania* spp., and *Trypanosoma brucei*. It plays a central role in protein degradation and turnover, essential processes for cell-cycle progression, apoptosis regulation, and overall parasite viability. Selective inhibitors have been developed that exploit structural differences between parasite and human proteasomes, making it a validated therapeutic target. Examples of such inhibitors include GNF6702 and LXE408.
Allosteric/catalytic inhibition at unique subunit interfaces
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Kinetoplastid Proteasome.